Rare diseases
Investigational molecules
Locations
Back to Germany27 clinical trials in Remscheid, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
GermanyA study testing duvakitug for patients with moderately to severely active ulcerative colitis
GermanyStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
GermanyStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
GermanyStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
GermanyStudy of MT-501 in patients with active Crohn's Disease or Ulcerative Colitis: A Phase 2 safety and effectiveness trial
GermanyA study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis
GermanyA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
GermanyStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
GermanyStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Significant research focusing on lung cancer treatments, including both non-small cell and small cell variants. Studies evaluating novel therapeutic approaches and comparing effectiveness of different treatment combinations.
Investigation of innovative therapies combined with standard treatments like chemotherapy and radiotherapy.
Comprehensive studies addressing various skin conditions, with particular emphasis on plaque psoriasis and chronic inflammatory disorders.
Multiple trials evaluating new biological therapies and their long-term safety profiles.
Innovative studies in cardiovascular medicine, focusing on preventing strokes and managing post-heart attack complications.
Evaluation of novel anticoagulants and treatments for improved patient outcomes.
Clinical research examining treatments for chronic gastrointestinal conditions, including ulcerative colitis and irritable bowel syndrome.
Studies exploring both conventional and innovative therapeutic approaches, including probiotics and biological treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
